Trial · NCT07464210
Nemtabrutinib, Bortezomib, and Rituximab for WM
NCT07464210, Phase 2, Not yet recruiting, Seoul National University Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Nemtabrutinib, Bortezomib, and Rituximab for WM. Trials, record NCT07464210. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07464210
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Nemtabrutinib, Bortezomib, and Rituximab for WM
- NCT number
- NCT07464210
- Status
- Not yet recruiting
- Phases
- Phase 2
- Enrollment
- 19 participants, estimated
- Lead sponsor
- Seoul National University Hospital
- Conditions
- Waldenstrom Macroglobulinemia
- Interventions
- NEBULA
- First posted
- 2026-03-11
- Last updated
- 2026-03-11
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Major response rate (MRR) | At the end of Cycle 6 (each cycle is 28 days) | Composite of complete response (CR) + very good partial response (VGPR) + partial response (PR) according to International Workshop on WM (IWWM)-11 response criteria |
| Secondary | Progression-free survival (PFS) | through study completion, an average of 2 years | Time from enrollment to first documentation of disease progression or death due to any cause, whichever occurs first |
| Secondary | Overall survival | through study completion, an average of 2 years | Time from enrollment to death from any cause |
| Secondary | Overall response rate (ORR) | At the end of Cycle 24 (each cycle is 28 days) | Composite of CR + VGPR + PR + minor response (MR) according to IWWM-11 response criteria |
| Secondary | complete response (CR) rate | At the end of Cycle 6 and Cycle 24 (each cycle is 28 days) | Response assessments will be based on the IWWM-11 criteria |
| Secondary | Time to response (TTR) | through study completion, an average of 2 years | Time to the first documentation of response (MR or better) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07464210
GET https://conductscience.org/api/trials/v1/NCT07464210/registered